Overweight women with diabetes can cut their risk for developing urinary incontinence (UI) by shedding 5% to 10% of their body weight or as little as 15 pounds (7.7 kg), according to findings from the Look AHEAD trial, a multicenter, randomized, controlled trial of overweight and obese individuals with type 2 diabetes.
Overweight women with diabetes can cut their risk for developing urinary incontinence (UI) by shedding 5% to 10% of their body weight or as little as 15 pounds (7.7 kg), according to findings from the Look AHEAD trial, a multicenter, randomized, controlled trial of overweight and obese individuals with type 2 diabetes.
The trial involved 2,739 women, 45 to 76 years of age, with body mass indices (BMI) of 25 kg/m2 or greater. The women were stratified into two groups. The first received intensive lifestyle intervention and modification counseling designed to promote weight loss of at least 7% per year. Professionals encouraged the women to consume low-calorie, low-fat diets, to control portions with liquid meal replacements, and to exercise at least 175 minutes per week. These women checked in weekly for 6 months and then three times monthly for another 6 months. The second group received far more limited diabetes support and education: In 1 year, they attended only three group sessions that focused on diet, physical activity, and social support.
At 1 year, those who lost the weight were 25% less likely to develop UI in general and 40% less likely to have stress UI. Each kilogram of weight lost reduced the odds of developing UI by 3% (P=0.01). Weight losses of 5% to 10% reduced the odds by almost half (47%; P=0.002).
Phelan S, Kanaya AM, Subak, LL. Weight loss prevents urinary incontinence in women with type 2 diabetes: Results from the Look AHEAD trial. J Urol. 2012;187(3):947-952.
Single iron infusion in late pregnancy significantly reduces anemia risk
January 22nd 2025A recent study found that a single dose of intravenous iron in the third trimester is superior to oral iron in reducing anemia rates in pregnant women, ensuring better outcomes for mother and baby.
Read More
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More